These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 24890092

  • 1. Overexpression of flotillin-1 is involved in proliferation and recurrence of bladder transitional cell carcinoma.
    Guan Y, Song H, Zhang G, Ai X.
    Oncol Rep; 2014 Aug; 32(2):748-54. PubMed ID: 24890092
    [Abstract] [Full Text] [Related]

  • 2. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
    Zhang Y, Li J, Song Y, Chen F, Pei Y, Yao F.
    Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
    [Abstract] [Full Text] [Related]

  • 3. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z, Zhang G, Kong C.
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [Abstract] [Full Text] [Related]

  • 4. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ, Baunoch DA, Stadler WM.
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Decreased expression of protein tyrosine phosphatase non-receptor type 12 is involved in the proliferation and recurrence of bladder transitional cell carcinoma.
    Piao Y, Liu X, Lin Z, Jin Z, Jin X, Yuan K, Wu W.
    Oncol Lett; 2015 Sep; 10(3):1620-1626. PubMed ID: 26622721
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epigenetic regulation of vascular endothelial growth factor a dynamic expression in transitional cell carcinoma.
    Ping SY, Shen KH, Yu DS.
    Mol Carcinog; 2013 Jul; 52(7):568-79. PubMed ID: 22392726
    [Abstract] [Full Text] [Related]

  • 11. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.
    Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, Lerner SP, Kim SJ.
    Cancer Res; 2004 Oct 15; 64(20):7355-60. PubMed ID: 15492256
    [Abstract] [Full Text] [Related]

  • 12. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP.
    Cancer; 2006 Jun 15; 106(12):2610-6. PubMed ID: 16700038
    [Abstract] [Full Text] [Related]

  • 13. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
    Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y, Wang X, Li J, Song L.
    Clin Cancer Res; 2011 May 15; 17(10):3089-99. PubMed ID: 21447726
    [Abstract] [Full Text] [Related]

  • 14. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E, Von Bonin F, Werner C, Wendt M, Schlott T.
    Int J Mol Med; 2006 Jan 15; 17(1):3-13. PubMed ID: 16328005
    [Abstract] [Full Text] [Related]

  • 15. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.
    Christoph F, Weikert S, Wolff I, Schostak M, Tabiti K, Müller M, Miller K, Schrader M.
    Cancer Lett; 2007 Jan 08; 245(1-2):121-6. PubMed ID: 16473461
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
    Shang C, Guo Y, Zhang H, Xue YX.
    Cancer Chemother Pharmacol; 2016 Mar 08; 77(3):507-13. PubMed ID: 26781446
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
    Aaltonen V, Boström PJ, Söderström KO, Hirvonen O, Tuukkanen J, Nurmi M, Laato M, Peltonen J.
    Am J Pathol; 1999 Mar 08; 154(3):755-65. PubMed ID: 10079253
    [Abstract] [Full Text] [Related]

  • 19. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
    Ham WS, Lee JH, Yu HS, Choi YD.
    Urology; 2008 Oct 08; 72(4):921-6. PubMed ID: 18387660
    [Abstract] [Full Text] [Related]

  • 20. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M, Hakenberg OW, Gunia S, Pohling P, Helke C, Lübbe L, Nowack R, Siegsmund M, Hoschke B.
    Urology; 2007 Sep 08; 70(3):449-53. PubMed ID: 17688921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.